The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
about
Novel therapeutic agents in neurogastroenterology: advances in the past year.New Options in Constipation Management.Gastrointestinal dysmotility disorders in critically ill dogs and cats.Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.Peripherally Acting µ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity.
P2860
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@en
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@nl
type
label
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@en
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@nl
prefLabel
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@en
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@nl
P2093
P2860
P1476
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
@en
P2093
Daniel D Long
David T Beattie
Pamela R Tsuruda
Ross G Vickery
Scott R Armstrong
P2860
P2888
P304
P356
10.1007/S00210-013-0850-7
P577
2013-04-04T00:00:00Z